en.wikipedia.org/wiki/Abdullahi_v._Pfizer,_Inc.

The Kano trovafloxacin trial litigation arose out of a clinical trial conducted by the .... ever been treated with Trovan, and then only after all other antibiotics failed.

law.justia.com/cases/federal/appellate-courts/ca7/17-2056/17-2056-2018-01-19.html

Jan 19, 2018 ... In Wyeth v. Levine, the Supreme Court held that claims against a manufacturer of a brand-name prescription drug for failure to warn adequately ...

www.justice.gov/usao/ma/news/Pfizer/Pfizer%20Settlement%20Agreement.pdf

Pfizer is a Delaware corporation with its principal place of business in New York. ... 05-12326 (D. Mass.); (4). United States et al. ex rel. Glenn DeMott v. Pfizer,.

www.haynesboone.com/-/media/files/practice-group-pdfs/fca_2017_review.ashx?la=en&hash=7E165A58DD673330577A9A7B46D70B438206B548

The False Claims Act, 31 U.S.C. §§ 3729 et seq. ... Jeremy Kernodle ..... Escobar did not resolve “whether all claims for ... weighed in to deepen the divide. In United States ex rel. Kelly v. Serco, Inc. ...... v. Pfizer, Inc., 847 F.3d 52, 57-58 (1st Cir.

www.haynesboone.com/-/media/files/newsletter/fca/fca_2016review.ashx?la=en&hash=961DDBE1A993C5A644FB209E499CFCD0D7FEA207

Jeremy Kernodle .... acquired by Pfizer) to resolve allegations that the ... v. Healthfirst case we discussed last year. See Kane v. Healthfirst Inc. et al., 11-cv- 02325 ...

etplusfacts.com/docs/default-source/pdfs/reply-brief-of-appellants023a6e494c2d68458196ff00006abc2d.pdf?sfvrsn=4

Jul 21, 2016 ... Jeremy D. Kernodle ... There Is No Serious Question That FHWA Has At All .... Anti-Discrimination Ctr. of Metro N.Y., Inc. v. ... Pfizer, Inc.,.

www.ncbi.nlm.nih.gov/pmc/articles/PMC3614971

Apr 2, 2013 ... By contrast, vancomycin (V) is a cell wall active agent. Here, we used a ... Linezolid was obtained from Pfizer Inc. (Groton, CT). Vancomycin ...... Kernodle DS, McGraw PA, Barg NL, Menzies BE, Voladri RK, et al. (1995) Growth ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC105607

and sulbactam (Pfizer Inc., New York, N.Y.) were used to prepare antibiotic solutions for kinetic .... The Ki value was determined as described by Galleni et al. (6).

onlinelibrary.wiley.com/doi/full/10.1002/ajmg.a.38418

Sep 10, 2017 ... Pediatric neuromuscular diseases encompass all disorders with ... Category, Compound, Action, Company, Dosing and delivery ..... function in CMT1A after 1 year versus placebo (Attarian et al., 2014). ..... Myostatin Inhibitors, PF‐06252616 , Inhibition of myostatin promotes muscle differentiation, Pfizer ...